Summary
We studied the expression of the glucose transporter GLUT 4 in the soleus and red gastrocnemius muscles from obese, diabetic (fa/fa) Zucker rats compared to their lean littermates (Fa/-), with and without treatment with the antidiabetic drug metformin. In the untreated groups of rats, the GLUT 4 content in a crude membrane fraction of both the soleus and the red gastrocnemius muscles were significantly lower in the obese (fa/fa) rats (3.46±0.28 vs. 6.04±0.41,p<0.001 and 6.0±0.24 vs. 9.1±0.48,p<0.0001, respectively). Differences in GLUT 4 expression in soleus muscle from the same rats were confirmed by quantitative immunofluorescence microscopy, and the results were significantly correlated with the results obtained from quantitative immunoblotting (rho=0.70,p<0.0005). The decreased expression of GLUT 4 in fa/fa rats could contribute to the well-established insulin resistance in skeletal muscle of these animals. After 4 weeks of treatment with metformin, weight gain was not affected in either the diabetic (fa/fa) rats or the lean (Fa/-) rats. Improvement of glucose homeostasis by metformin was not associated with normalization of the GLUT 4 expression in the skeletal muscles studied, indicating (1) that the decreased GLUT 4 expression is not directly related to hyperinsulinaemia and diabetes mellitus and (2) that metformin does not normalize the expression of GLUT 4 in skeletal muscle of the diabetic (fa/fa) Zucker rats.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sterne J (1969) Pharmacology and mode of action of the hypoglycemic guanidine derivates. In: Campbell GD (ed) Oral hypoglycemic agents. Academic Press, New York, pp 193–245
Bailey CJ (1988) Metformin revisited: its actions and indications for use. Diabetic Med 5:315–320
Jackson RA, Hawa MI, Jaspan JB et al. (1987) Mechanism of metformin action in non-insulin-dependent diabetes. Diabetes 36: 632–640
Wu MS, Johnston P, Sheu WH-H et al. (1990) Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care 13:1–8
Lorch E (1971) Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin-diabetic rat. Diabetologia 7:195–203
Meyer F, Ipaktchi M, Caluser H (1967) Specific inhibition of gluconeogenesis by biguanides. Nature (Lond) 213:203–204
DeFronzo RA, Barzilai N, Simonson DC (1991) Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol. Metab 73:1294–1301
Klip A, Leiter LA (1990) Cellular mechanism of action of metformin. Diabetes Care 13:696–704
Hother-Nielsen O, Schmitz O, Andersen PH, Beck-Nielsen H, Pedersen O (1989) Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. Acta Endocrinol 120:257–265
Pedersen O, Nielsen OH, Bak J, Richelsen B, Beck-Nielsen H, Schwartz-Sørensen N (1989) The effect of metformin on adipocyte insulin action and metabolic control in obese subjects with type II diabetes. Diabetic Med 6:249–256
Matthaei S, Hamann A, Klein HH et al. (1991) Association of metformin's effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes. Diabetes 40:850–857
Galuska D, Zierath J, Thorne A, Sonnenfield T, Wallberg-Henriksson H (1991) Metformin increases insulin-stimulated glucose transport in insulin-resistant human skeletal muscle. Diabet Metab 17:159–163
Burant CF, Sivitz WI, Fukumoto H et al. (1991) Mammalian glucose transporters: structure and molecular regulation. Rec Prog Horm Res 47:349–387
Kern M, Wells JA, Stephens JM et al. (1990) Insulin responsiveness in skeletal muscle is determined by glucose transporter (GLUT 4) protein level. Biochem J 270:397–400
Ploug T, Stallknecht BM, Pedersen O et al. (1990) Effect of endurance training on glucose transport capacity and glucose transporter expression in rat skeletal muscle. Am J Physiol 259:E778-E786
Zucker LM, Antoniades HN (1972) Insulin and obesity in the Zucker genetically obese rat “fatty”. Endocrinology 90: 1320–1330
Becker-Zimmerman K, Berger M, Berchtold P, Gries FA, Herberg L, Schwenen M (1982) Treadmill training improves intravenous glucose tolerance and insulin sensitivity in fatty Zucker rats. Diabetologia 22:468–474
Ionescu E, Sauter JF, Jeanrenaud B (1985) Abnormal oral glucose tolerance in genetically obese (fa/fa) rats. Am J Physiol 248: E500-E506
Crettaz M, Prentki M, Zanietti D, Jeanrenaud B (1980) Insulin resistance in soleus muscles from obese Zucker rats. Involvement of several defective sites. Biochem J 186:525–534
Penicaud L, Ferre P, Terretaz J et al. (1987) Development of obesity in Zucker rats: early insulin resistance in muscles but normal sensitivity in white adipose tissue. Diabetes 36: 626–631
Sherman WM, Katz AL, Cutler CL, Withers RT, Ivy JL (1988) Glucose transport: locus of muscle insulin resistance in obese Zucker rats. Am J Physiol 255:E374-E382
Klip A, Ramlal T, Young DA, Holloszy JO (1987) Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett 224: 224–230
Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J (1990) Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33:625–627
Handberg A, Kayser L, Høyer PE, Vinten J (1992) A substantial part of GLUT-1 in crude membranes from muscle originates from perineurial sheaths. Am J Physiol 262:E721-E727
Jericevic Z, Wiese B, Bryan J, Smith LC (1989) Validation of an imaging system: steps to evaluate and validate a microscope imaging system for quantitative studies. In: Taylor DL, Wang Y-L (eds) Methods in cell biology. Academic Press, New York, pp 47–83
Kolterman OG, Gray RS, Griffin J et al. (1981) Receptor and postreceptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus. J Clin Invest 68:957–969
Ciaraldi TP, Kolterman OG, Scarlett JA, Kao M, Olefsky JM (1982) Role of the glucose transport system in the postreceptor defect of non-insulin dependent diabetes mellitus. Diabetes 31: 1061–1022
DeFronzo RA (1988) The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667–687
Hirschman MF, Goodyear LJ, Wardzala LJ, Horton ED, Horton ES (1990) Identification of an intracellular pool of glucose transporters from basal and insulin-stimulated rat skeletal muscle. J Biol Chem 265:987–991
Douen AG, Ramlal T, Rastogi S et al. (1990) Exercise induces recruitment of the “insulin-responsive glucose transporter”. J Biol Chem 265: 13427–13430
Rodnick KJ, Slot JW, Studelska DR et al. (1992) Immunocytochemical and biochemical studies of GLUT 4 in rat skeletal muscle. J Biol Chem 267:6278–6285
Pedersen O, Bak JF, Andersen PH et al. (1990) Evidence against altered expression of GLUT 1 or GLUT 4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39:865–870
Kahn BB, Rosetti L, Lodish HF, Charron MJ (1991) Decreased in vivo glucose uptake but normal expression of GLUT 1 and GLUT 4 in skeletal muscle of diabetic rats. J Clin Invest 87: 2197–2206
Strout HV, Vicario PP, Biswas C et al. (1990) Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle. Endocrinology 126:2728–2732
Friedman JE, Sherman WM, Reed MJ, Elton CW, Dohn GL (1990) Exercise training increases glucose transporter protein GLUT 4 in skeletal muscle of obese Zucker (fa/fa) rats. FEBS Lett 268:13–16
Zarjevski N, Doyle P, Jeanrenaud B (1992) Muscle insulin resistance may not be a primary etiological factor in the genetically obese fa/fa rat. Endocrinology 130:1564–1570
Koranyi L, James D, Mueckler M, Permutt MA (1990) Glucose transporter levels in spontaneously obese (db/db) insulin-resistant mice. J Clin Invest 85: 962–967
Slieker LJ, Sundell KL, Heath WF et al. (1992) Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/drt) and viable yellow mouse (Avy/a). Diabetes 41: 187–193
Hager SR, Pastorek D, Jochen AL, Meier D (1991) Divergence between GLUT 4, RNA and protein abundance in skeletal muscle of insulin resistant rats. Biochem Biophys Res Commun 181:240–245
Haber RS, Weinstein SP (1992) Role of glucose transporters in glucocorticoid-induced insulin resistance. GLUT 4 isoform in rat skeletal muscle is not decreased by dexamethasone. Diabetes 41:728–735
Cusin I, Terretaz J, Rohner-Jeanrenaud F, Zarjevski N, Assimacopoulos-Jeannet F, Jeanrenaud B (1990) Hyperinsulinemia increases the amount of GLUT 4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance. Endocrinology 127:3246–3248
Friedman JE, De Vente JE, Peterson RG, Dohm GL (1991) Altered expression of muscle glucose transporter GLUT 4 in diabetic fatty Zucker rats (ZDF/Drt-fa). Am J Physiol 261: E782-E788
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Handberg, A., Kayser, L., Høyer, P.E. et al. Metformin ameliorates diabetes but does not normalize the decreased GLUT 4 content in skeletal muscle of obese (fa/fa) Zucker rats. Diabetologia 36, 481–486 (1993). https://doi.org/10.1007/BF02743261
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02743261